We are proud to announce that the AIR-MT project has been selected for funding by Inserm ImpactSanté program (€3M), with CIML researcher Béatrice Nal as a key partner.
The project will use artificial intelligence to design optimized RNAs for more effective vaccines and therapies. #France2030.